Eli Lilly CEO admits insulin could be cheaper after Twitter chaos

A phony tweet announcing that insulin was free sent global insulin makers down on stock markets – and renewed debate about the drug’s pricing in the US.

Photo: Mike Blake/Reuters/Ritzau Scanpix

Thursday, Nov. 10, did not go down quietly at Eli Lilly headquarters.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs